{"title":"Current Trends of Artificial Intelligence in Nanosciences Application","authors":"G. Dagnaw, Gubala Getu Endeshaw","doi":"10.11648/J.NS.20190404.14","DOIUrl":null,"url":null,"abstract":"Nanotechnologies are being spoken of as the driving force behind a new industrial revolution. Both private and public-sector spending are constantly increasing. In recent years the industries like Automobile, Medical, Space, Communication, Space and Military have realized tremendous benefits originating from discoveries made in the fields of Nanotechnology, Robotics and Artificial Intelligence (NRAI).During the last decade there has been increasing use of artificial intelligence tools in nanotechnology research. Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing the goal of precision medicine tailoring the best treatment for each cancer patient. Recent conversion between these two fields is enabling better patient data acquisition and improved design of nonmaterial’s for precision cancer medicine. Diagnostic nonmaterial’s are used to assemble a patient-specific disease profile, which is then leveraged, through a set of therapeutic nanotechnologies, to improve the treatment outcome. However, high intratumor and interpatient heterogeneities make the rational design of diagnostic and therapeutic platforms, and analysis of their output, extremely difficult. Integration of AI approaches can bridge this gap, using pattern analysis and classification algorithms for improved diagnostic and therapeutic accuracy. Nanomedicine design also benefits from the application of AI, by optimizing material properties according to predicted interactions with the target drug, biological fluids, immune system, vasculature, and cell membranes, all affecting therapeutic efficacy. Here, fundamental concepts in AI are described and the contributions and promise of nanotechnology coupled with AI to the future of precision cancer medicine are reviewed. Nanoscale applications working alone and in concert with AI will begin to move from the laboratories of the world into the theatres of war. Just as AI systems are now being wholly integrated into military decision making processes such as allowing satellites to deter attacks autonomously, in complimentary fashion, nanotechnology is providing the fabric for military space development.","PeriodicalId":88069,"journal":{"name":"Nuclear science abstracts","volume":"67 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear science abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.NS.20190404.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Nanotechnologies are being spoken of as the driving force behind a new industrial revolution. Both private and public-sector spending are constantly increasing. In recent years the industries like Automobile, Medical, Space, Communication, Space and Military have realized tremendous benefits originating from discoveries made in the fields of Nanotechnology, Robotics and Artificial Intelligence (NRAI).During the last decade there has been increasing use of artificial intelligence tools in nanotechnology research. Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing the goal of precision medicine tailoring the best treatment for each cancer patient. Recent conversion between these two fields is enabling better patient data acquisition and improved design of nonmaterial’s for precision cancer medicine. Diagnostic nonmaterial’s are used to assemble a patient-specific disease profile, which is then leveraged, through a set of therapeutic nanotechnologies, to improve the treatment outcome. However, high intratumor and interpatient heterogeneities make the rational design of diagnostic and therapeutic platforms, and analysis of their output, extremely difficult. Integration of AI approaches can bridge this gap, using pattern analysis and classification algorithms for improved diagnostic and therapeutic accuracy. Nanomedicine design also benefits from the application of AI, by optimizing material properties according to predicted interactions with the target drug, biological fluids, immune system, vasculature, and cell membranes, all affecting therapeutic efficacy. Here, fundamental concepts in AI are described and the contributions and promise of nanotechnology coupled with AI to the future of precision cancer medicine are reviewed. Nanoscale applications working alone and in concert with AI will begin to move from the laboratories of the world into the theatres of war. Just as AI systems are now being wholly integrated into military decision making processes such as allowing satellites to deter attacks autonomously, in complimentary fashion, nanotechnology is providing the fabric for military space development.